R. Shegokar
AuthID: R-007-2HV
11
TÃTULO: Role of Excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs/NLCs)
AUTORES: Slavomira Doktorovova; Ranjita Shegokar; Eliana B Souto ;
PUBLICAÇÃO: 2017, FONTE: Nanostructures for Novel Therapy: Synthesis, Characterization and Applications
AUTORES: Slavomira Doktorovova; Ranjita Shegokar; Eliana B Souto ;
PUBLICAÇÃO: 2017, FONTE: Nanostructures for Novel Therapy: Synthesis, Characterization and Applications
12
TÃTULO: Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying
AUTORES: Slavomira Doktorovova; Ranjita Shegokar; Lisete Fernandes; Paula Martins Lopes ; Amelia M Silva ; Rainer H Mueller; Eliana B Souto ;
PUBLICAÇÃO: 2014, FONTE: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, VOLUME: 19, NÚMERO: 8
AUTORES: Slavomira Doktorovova; Ranjita Shegokar; Lisete Fernandes; Paula Martins Lopes ; Amelia M Silva ; Rainer H Mueller; Eliana B Souto ;
PUBLICAÇÃO: 2014, FONTE: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, VOLUME: 19, NÚMERO: 8
13
TÃTULO: Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN) Full Text
AUTORES: Doktorovova, S; Shegokar, R; Martins Lopes, P ; Silva, AM ; Lopes, CM ; Mueller, RH; Souto, EB ;
PUBLICAÇÃO: 2012, FONTE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 45, NÚMERO: 5
AUTORES: Doktorovova, S; Shegokar, R; Martins Lopes, P ; Silva, AM ; Lopes, CM ; Mueller, RH; Souto, EB ;
PUBLICAÇÃO: 2012, FONTE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 45, NÚMERO: 5
